Federica Trovato

Dr. Federica Trovato

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
31 March 2024 in Cosmetics
Verified
Journal Article
Open access
PDF file
Federica TrovatoFederica Trovato
Federica Trovato
SCStefano Ceccarelli
Stefano Ceccarelli
SMSimone Michelini
Simone Michelini
Giordano VespasianiGiordano Vespasiani
Giordano Vespasiani
SGStefania Guida
Stefania Guida
GPGiovanni Pellacani
Giovanni Pellacani
The growing interest in maintaining a youthful appearance has encouraged an accelerated development of innovative, minimally invasive aesthetic treatments for facial rejuvenation and regeneration. The close correlation between tissue repair, regeneration, and aging has paved the way for the application of regenerative medicine principles in cosmetic dermatology. The theoretical substrates of regenerative medicine applications in dermo-aesthetics are plentiful. However, regenerative dermatology is an emerging field and needs more data and in vivo trials to reach a consensus on the standardization of methods. In this review, we summarize the principles of regenerative medicine and techniques as they apply to cosmetic dermatology, suggesting unexplored fields and future directions.

24 July 2025 in Cosmetics
Verified
Journal Article
Open access
PDF file
AGAntonio Di Guardo
Antonio Di Guardo
Federica TrovatoFederica Trovato
Federica Trovato
Carmen CantisaniCarmen Cantisani
Carmen Cantisani
ADAnnunziata Dattola
Annunziata Dattola
Steven NisticòSteven Nisticò
Steven Nisticò
Alessia PaganelliAlessia Paganelli
Alessia Paganelli
Artificial intelligence (AI) and machine learning (ML) are increasingly transforming the landscape of cosmetic formulation, enabling the development of safer, more effective, and personalized products. This article explores how AI-driven predictive modeling is applied across various components of cosmetic products, including surfactants, polymers, fragrances, preservatives, antioxidants, and prebiotics. These technologies are employed to forecast critical properties such as texture, stability, and shelf-life, optimizing both product performance and user experience. The integration of computational toxicology and ML algorithms also allows for early prediction of skin sensitization risks, including the likelihood of adverse events such as allergic contact dermatitis. Furthermore, AI models can support efficacy assessment, bridging formulation science with dermatological outcomes. The article also addresses the ethical, regulatory, and safety challenges associated with AI in cosmetic science, underlining the need for transparency, accountability, and harmonized standards. The potential of AI to reshape dermocosmetic innovation is vast, but it must be approached with robust oversight and a commitment to user well-being.

8 December 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
AGAntonio Di Guardo
Antonio Di Guardo
Federica TrovatoFederica Trovato
Federica Trovato
Carmen CantisaniCarmen Cantisani
Carmen Cantisani
FRFrancesco Ricci
Francesco Ricci
GLGiovanni Di Lella
Giovanni Di Lella
LFluca Fania
luca Fania
Advanced cutaneous squamous cell carcinoma (aCSCC) comprises locally advanced and metastatic disease not amenable to curative surgery or radiotherapy and is associated with substantial morbidity, mortality, and healthcare costs. This narrative review summarizes current knowledge on the epidemiology, biology, clinical presentation, and staging of aCSCC and critically appraises therapeutic strategies with a focus on programmed death 1 (PD-1) blockade. Immune checkpoint inhibitors now represent the main systemic treatment for advanced cSCC, with clinical trials and observational studies reporting response rates around 45–60%, sustained benefit in a subset of patients, and a manageable yet clinically relevant profile of immune-related toxicities. However, outcomes remain heterogeneous, particularly in elderly, comorbid, and immunosuppressed patients. We therefore review established and emerging prognostic determinants spanning clinical, anatomical, histopathological, metabolic, inflammatory, and on-treatment domains. Priorities for biomarker-enriched studies and harmonized real-world registries to enable more refined risk stratification and genuinely personalized, multidisciplinary management of aCSCC are also outlined.

26 November 2024 in Journal of Cosmetic Dermatology
Verified
Journal Article
Open access
GVGiordano Vespasiani
Giordano Vespasiani
Federica TrovatoFederica Trovato
Federica Trovato
RGRicci Giuseppina
Ricci Giuseppina
MSMichelini Simone
Michelini Simone
PGPellacani Giovanni
Pellacani Giovanni

7 September 2023 in Nutrients
Verified
Journal Article
Open access
PDF file
IPIlaria Proietti
Ilaria Proietti
ETErsilia Tolino
Ersilia Tolino
NBNicoletta Bernardini
Nicoletta Bernardini
Federica TrovatoFederica Trovato
Federica Trovato
VAVizzaccaro Andrea
Vizzaccaro Andrea
CPConcetta Potenza
Concetta Potenza
The correlation between health and diet has always been a subject of interest in the field of dermatology and medicine in general. However, studies in the literature are still scarce, and need further investigation in the field of inflammatory skin diseases. In this paper, we report a case of a patient with atopic dermatitis whose complete recovery occurred only after combining dupilumab therapy with a Mediterranean diet regimen.

8 September 2025 in Drugs in Context
Verified
Journal Article
Open access
ADAnnunziata Dattola
Annunziata Dattola
NBNicoletta Bernardini
Nicoletta Bernardini
JAJasmine Anedda
Jasmine Anedda
LALaura Atzori
Laura Atzori
CBClaudio Bonifati
Claudio Bonifati
CPConcetta Potenza
Concetta Potenza
This article aims to evaluate the effect of IL-23 inhibitors on clinical outcomes and progression of PsA in patients with moderate-to-severe psoriasis and early musculoskeletal involvement.